139 related articles for article (PubMed ID: 34604873)
1.
Liang Y; Zhao J; Zou H; Zhang J; Zhang T
Food Funct; 2021 Nov; 12(21):10667-10675. PubMed ID: 34604873
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, in vitro and in silico evaluation of anti-colorectal cancer activity of curcumin analogues containing 1,3-diphenyl-1H-pyrazole targeting EGFR tyrosine kinase.
Doan NQH; Nguyen NTK; Nguyen NB; Tran TT; Tran QN; Truong TN
Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130414. PubMed ID: 37331408
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory activities of 20(R, S)-protopanaxatriol against epidermal growth factor receptor tyrosine kinase.
Zhao J; Zhang T; Liang Y; Zou H; Zhang J
Food Chem Toxicol; 2021 Sep; 155():112411. PubMed ID: 34271119
[TBL] [Abstract][Full Text] [Related]
4. In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors.
Saeed MEM; Yücer R; Dawood M; Hegazy MF; Drif A; Ooko E; Kadioglu O; Seo EJ; Kamounah FS; Titinchi SJ; Bachmeier B; Efferth T
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409325
[TBL] [Abstract][Full Text] [Related]
5. Identification of 20(
Liang Y; Zhao J; Zou H; Zhang J; Zhang T
Oxid Med Cell Longev; 2022; 2022():6119737. PubMed ID: 35111279
[TBL] [Abstract][Full Text] [Related]
6. Ensemble docking and molecular dynamics identify knoevenagel curcumin derivatives with potent anti-EGFR activity.
Yadav IS; Nandekar PP; Srivastavaa S; Sangamwar A; Chaudhury A; Agarwal SM
Gene; 2014 Apr; 539(1):82-90. PubMed ID: 24491504
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis,
Matada GSP; Abbas N; Dhiwar PS; Basu R; Devasahayam G
Anticancer Agents Med Chem; 2021; 21(4):451-461. PubMed ID: 32698735
[TBL] [Abstract][Full Text] [Related]
8. Preparation, Characterization and In Vitro Biological Evaluation of Novel Curcumin Derivatives as Cytotoxic and Apoptosis-Inducing Agents.
Arjomandi OK; Almasi S; Hosseinzadeh L; Kavoosi M; Adibi H
Anticancer Agents Med Chem; 2021; 21(10):1309-1322. PubMed ID: 33006540
[TBL] [Abstract][Full Text] [Related]
9. Computational analyses of curcuminoid analogs against kinase domain of HER2.
Yim-im W; Sawatdichaikul O; Semsri S; Horata N; Mokmak W; Tongsima S; Suksamrarn A; Choowongkomon K
BMC Bioinformatics; 2014 Aug; 15(1):261. PubMed ID: 25089037
[TBL] [Abstract][Full Text] [Related]
10. Identification of Vinyl Sulfone Derivatives as EGFR Tyrosine Kinase Inhibitor: In Vitro and In Silico Studies.
Aiebchun T; Mahalapbutr P; Auepattanapong A; Khaikate O; Seetaha S; Tabtimmai L; Kuhakarn C; Choowongkomon K; Rungrotmongkol T
Molecules; 2021 Apr; 26(8):. PubMed ID: 33921332
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of anthrax lethal factor by curcumin and chemically modified curcumin derivatives.
Antonelli AC; Zhang Y; Golub LM; Johnson F; Simon SR
J Enzyme Inhib Med Chem; 2014 Oct; 29(5):663-9. PubMed ID: 24102525
[TBL] [Abstract][Full Text] [Related]
12. Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy.
Lee JY; Lee YM; Chang GC; Yu SL; Hsieh WY; Chen JJ; Chen HW; Yang PC
PLoS One; 2011; 6(8):e23756. PubMed ID: 21858220
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAF
Al-Wahaibi LH; Gouda AM; Abou-Ghadir OF; Salem OIA; Ali AT; Farghaly HS; Abdelrahman MH; Trembleau L; Abdu-Allah HHM; Youssif BGM
Bioorg Chem; 2020 Nov; 104():104260. PubMed ID: 32920363
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis and Biological Evaluation of Benzohydrazide Derivatives Containing Dihydropyrazoles as Potential EGFR Kinase Inhibitors.
Wang HC; Yan XQ; Yan TL; Li HX; Wang ZC; Zhu HL
Molecules; 2016 Aug; 21(8):. PubMed ID: 27527130
[TBL] [Abstract][Full Text] [Related]
15. Curcumin inhibition of the functional interaction between integrin α6β4 and the epidermal growth factor receptor.
Soung YH; Chung J
Mol Cancer Ther; 2011 May; 10(5):883-91. PubMed ID: 21388972
[TBL] [Abstract][Full Text] [Related]
16. Computational Evaluation and In Vitro Validation of New Epidermal Growth Factor Receptor Inhibitors.
Gómez-Ganau S; Castillo J; Cervantes A; de Julián-Ortiz JV; Gozalbes R
Curr Top Med Chem; 2020; 20(18):1628-1639. PubMed ID: 32493189
[TBL] [Abstract][Full Text] [Related]
17. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R
Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234
[TBL] [Abstract][Full Text] [Related]
18. Anti-Proliferative Potential of Fluorinated Curcumin Analogues: Experimental and Computational Analysis and Review of the Literature.
Hatamipour M; Hadizadeh F; Jaafari MR; Khashyarmanesh Z; Sathyapalan T; Sahebkar A
Curr Med Chem; 2022 Mar; 29(8):1459-1471. PubMed ID: 34514978
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterisation, and in vitro anticancer activity of curcumin analogues bearing pyrazole/pyrimidine ring targeting EGFR tyrosine kinase.
Ahsan MJ; Khalilullah H; Yasmin S; Jadav SS; Govindasamy J
Biomed Res Int; 2013; 2013():239354. PubMed ID: 24089667
[TBL] [Abstract][Full Text] [Related]
20. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
El-Sayed NA; Nour MS; Salem MA; Arafa RK
Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
